However, LAM represents a diffuse cystic lung disease associated with proliferation of so called perivascular epithelioid cells that characteristically show aberrant expression of melanocytic markers (e.g. HMB45, Melan A) and therefore their use will help to exclude the diagnosis of LAM at immunohistochemical level. Here, PMEL is linked to lymphangioleiomyomatosis.